{"hq_id":"hq-p-spe-000090","name":"Colloidal Silver Supplements (Argyria, FDA Warnings, No Efficacy)","category":{"primary":"specialty","secondary":"supplements","tags":["colloidal silver","argyria","FDA warning","antibiotic resistance","blue skin","supplement"]},"product_tier":"SPE","overall_risk_level":"moderate","description":"Colloidal silver marketed as antimicrobial supplement despite FDA ruling (1999) that OTC colloidal silver products are 'not generally recognized as safe and effective.' Causes argyria — irreversible blue-gray skin discoloration from silver deposition. No proven therapeutic benefit for any condition. Promotes antibiotic resistance by encouraging avoidance of evidence-based antibiotics. Silver generators marketed for home production lack quality control.","synthesis":{"derived_risk_level":"moderate","synthesis_confidence":0.5,"synthesis_method":"compound_composition","context_used":"human_adult","context_source":"product_users","exposure_modifier":0.977,"vulnerability_escalated":false,"escalation_reason":null,"compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-05-09","synthesis_version":"1.2.0","methodology_note":"exposure_modifier and adjusted_magnitude are computed from ALETHEIA-calibrated heuristics (route × duration × frequency multipliers, clamped to [0.5, 1.4]). Multipliers are directionally informed by EPA Exposure Factors Handbook (2011) and CalEPA OEHHA but are not regulatory consensus. See /api/methodology for full disclosure."},"hazard_summary":{"sensitive_populations":"anyone using colloidal silver (no safe therapeutic use)","overall_risk":"moderate","primary_concerns":["Argyria: irreversible blue-gray skin discoloration","FDA 1999: not safe and effective for any OTC use","No proven therapeutic benefit for any condition","Promotes antibiotic avoidance — contributes to resistance crisis"],"exposure_routes":"Oral ingestion (primary); topical (marketed for wound care)"},"exposure":{"routes":["oral"],"contact_types":["oral_direct"],"users":["adult"],"duration":"minutes","frequency":"daily","scenarios":["Daily oral consumption causing cumulative silver deposition","Argyria: irreversible blue-gray skin discoloration","No proven therapeutic benefit for any condition","Promotes antibiotic avoidance — contributes to resistance"],"notes":"FDA 1999: colloidal silver products are 'not generally recognized as safe and effective.' Multiple FDA warning letters to manufacturers. EPA oral RfD for silver: 5 μg/kg/day (argyria threshold). Home silver generators: uncontrolled particle size, concentration, and purity. Argyria cases documented from as little as 1 gram cumulative silver intake."},"consumer_guidance":{"usage_warning":"FDA has ruled colloidal silver is NOT safe and effective for any OTC use. Argyria is irreversible. No legitimate medical use as oral supplement. Do not substitute colloidal silver for antibiotics — promotes resistance. Report sellers making health claims to FDA.","safer_alternatives":["Evidence-based medicine for infections (antibiotics prescribed by physician)","Wound care: FDA-approved topical silver dressings (Silvadene — different from supplements)","No supplement alternative needed — colloidal silver has no proven benefit"],"red_flags":[{"indicator":"Health claims without FDA approval or clinical evidence","meaning":"Product efficacy unverified.","action":"Consult physician. Check FDA and clinical trial evidence."}],"green_flags":[{"indicator":"FDA-approved, USP-verified, or physician-recommended","meaning":"Verified safety and/or efficacy through established evaluation.","verification":"Check FDA approval status, USP mark, or published clinical evidence."}],"what_to_ask":[{"question":"Is there FDA-approved or peer-reviewed clinical evidence for this product?","why_it_matters":"Health products without evidence may be ineffective or harmful.","good_answer":"FDA-approved or supported by published RCTs.","bad_answer":"Testimonials only or DSHEA-exempt supplement with no clinical evidence."}],"alternatives":[{"name":"Evidence-based medicine for infections","notes":"antibiotics prescribed by physician"},{"name":"Wound care: FDA-approved topical silver dressings","notes":"Silvadene — different from supplements"},{"name":"No supplement alternative needed — colloidal silver has no proven benefit","notes":"Alternative"}]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"FDA Final Rule: OTC Colloidal Silver (1999)","citation":"64 FR 44653","requirements":"Colloidal silver products not generally recognized as safe and effective for any OTC drug use. Any therapeutic claims make product an unapproved new drug.","compliance_status":null,"effective_date":"1999-08-17","enforcing_agency":"FDA","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":true,"disposal_guidance":"Regular waste.","hazardous_waste":false,"expected_lifespan":"1-2_years"},"formulation":{"form":"varies","key_ingredients":[{"hq_id":"hq-c-mix-000022","name":"Nano silver","role":"active_ingredient","concentration_pct":"10-500 ppm silver"}],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-mix-000022","compound_name":null,"role":"active_ingredient","typical_concentration":"10-500 ppm silver"}],"identifiers":{"common_names":["colloidal silver supplements (argyria, fda warnings, no efficacy)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"3M","manufacturer":"3M","market_position":"mass_market","notable":"Safety and specialty product conglomerate"},{"brand":"Honeywell","manufacturer":"Honeywell","market_position":"mass_market","notable":"Safety equipment and technology"},{"brand":"DuPont","manufacturer":"DuPont","market_position":"professional","notable":"Chemical and safety products"}],"brand_examples_disclaimer":"Representative branded products of this category. Concerning ingredients listed in materials.concerning[] apply to the category, not necessarily to every named brand. Specific formulations vary by SKU and may have changed since this record was written; consult the brand's current ingredient label before drawing brand-level conclusions.","sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-25"},{"type":"regulation","title":"FDA Final Rule: OTC Colloidal Silver (1999) (64 FR 44653)","jurisdiction":"USA","year":1999,"citation":"64 FR 44653","id":"src_d8bfce1a"},{"id":"epa_nano_silver_registration","type":"regulatory","title":"US EPA: Registration Review of Nano Silver and Related Pesticide Products — AgNP Antimicrobial Registration, Aquatic Life Risk Assessment, Ag⁺ Dissolution Mechanism, and Argyria Risk","year":2015,"inherited_from_compound":"hq-c-mix-000022"},{"id":"atsdr_silver_tox","type":"regulatory","title":"ATSDR: Toxicological Profile for Silver — Argyria, Dermal Discoloration, Colloidal Silver Supplement Risk, Occupational Exposure, and Systemic Effects at High Doses","year":1990,"inherited_from_compound":"hq-c-mix-000022"},{"type":"regulatory","title":"US Food and Drug Administration (FDA)","jurisdiction":"USA","id":"src_82d1cfcd","extraction":"description_reference"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-14T01:22:10.098Z"}}